Disease Index
9,486 diseasesmycosis fungoides
Human disease
MeSH: D009182
mycosis fungoides and variants
myelocystocele
human disease
myelodysplastic syndrome
diverse collection of blood-related medical conditions with ineffective production of the myeloid class of blood cells
ICD: D46MeSH: D009190
myelodysplastic syndrome with excess blasts-1
myelodysplastic syndrome defined by 5-9% blasts in the bone marrow, and <5% blasts in the blood. Approximately 25% of cases progress to an acute leukemia. (WHO)
myelodysplastic syndrome with excess blasts-2
myelodysplastic syndrome defined by 10-19% blasts in the bone marrow or 5-19% blasts in the blood and <10% blasts in the bone marrow. Approximately 33% of cases progress to acute leukemia. The prognosis is usually poor. (WHO)
myelodysplastic–myeloproliferative diseases
medical condition
MeSH: D054437
myelofibrosis
myeloid neoplasm that is located in the bone marrow which results in bone marrow being replaced by fibrous (scar) tissue
MeSH: D055728
myeloid hemopathy
human disease
myeloid neoplasm associated with FGFR1 rearrangement
myeloid neoplasm associated with PDGFRA rearrangement
myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1
human disease
myeloid neoplasms associated with PDGFRB rearrangement
myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1 that is characterized by the rearrangement of the PDGFRB gene, most often resulting in the formation of ETV6-PDGFRB fusion transcripts
ICD: D47.1
myeloid sarcoma
solid tumor composed of immature white blood cells called myeloblasts.
MeSH: D023981
myelomeningocele
spina bifida characterized by protrusion of the spinal cord through an opening, covered by meningeal membranes
MeSH: D008591
Myeloperoxidase deficiency
human disease
MeSH: C562864
myeloproliferative neoplasm
myeloid neoplasm that is characterized by a group of slow growing blood cancers in which large numbers of abnormal red blood cells, white blood cells, or platelets grow and spread in the bone marrow and the peripheral blood
ICD: D47.1
myeloproliferative neoplasm, unclassifiable
This subgroup of myeloproliferative neoplasms includes cases which do not meet the morphologic criteria of any of the defined myeloproliferative neoplasms, or which have characteristics that overlap at least two of the myeloproliferative neoplasms
MYH7-related late-onset scapuloperoneal muscular dystrophy
human disease
MYH9-related disorder
blood platelet disease that has material basis in mutations in the MYH9 gene. It is characterized by thrombocytopenia, enlarged platelets, sensorineural hearing loss and presenile cataract
Myhre syndrome
medical condition
MeSH: C537620
myiasis
parasitic ectoparasitic infectious disease that is caused by parasitic dipterous fly larvae (maggots) feeding on the host's necrotic or living tissue
MeSH: D009198
MYO5B-related progressive familial intrahepatic cholestasis
human disease
myoclonic dystonia
dystonia characterized by myoclonic jerks affecting mostly proximal muscles and dystonia, usually torticollis or writer's cramp, that typically responds to alcohol and has onset in the first of second decade of life
myoclonic dystonia 11
myoclonic dystonia characterized by autosomal dominant inheritance and association with psychiatric disorder that has material basis in heterozygous mutation in the SGCE gene on chromosome 7q21
myoclonic dystonia 15
myoclonic dystonia characterized by autosomal dominant inheritance that has material basis in variation in the chromosome region 18p11
MeSH: C538002
myoclonic epilepsy in non-progressive encephalopathies
human disease
myoclonic epilepsy of infancy
human disease
myoclonus
medical sign, rapid involuntary irregular muscle contractions
ICD: G25.3MeSH: D009207
myoclonus-cerebellar ataxia-deafness syndrome
This syndrome is characterised by the association of myoclonus, cerebellar ataxia and sensorineural hearing loss
MeSH: C563549